Clinical practice utilizes the status of estrogen receptor (ER), progesterone receptor (PR), and HER2 hormone receptors to categorize breast cancer, enabling the optimization of personalized therapeutic strategies for each patient [9,10]. The gene discussed is ESR1; the disease is breast carcinoma.